Literature DB >> 25853627

Stress-related anhedonia is associated with ventral striatum reactivity to reward and transdiagnostic psychiatric symptomatology.

N S Corral-Frías1, Y S Nikolova2, L J Michalski3, D A A Baranger3, A R Hariri2, R Bogdan1.   

Abstract

BACKGROUND: Early life stress (ELS) is consistently associated with increased risk for subsequent psychopathology. Individual differences in neural response to reward may confer vulnerability to stress-related psychopathology. Using data from the ongoing Duke Neurogenetics Study, the present study examined whether reward-related ventral striatum (VS) reactivity moderates the relationship between retrospectively reported ELS and anhedonic symptomatology. We further assessed whether individual differences in reward-related VS reactivity were associated with other depressive symptoms and problematic alcohol use via stress-related anhedonic symptoms and substance use-associated coping.
METHOD: Blood oxygen level-dependent functional magnetic resonance imaging (fMRI) was collected while participants (n = 906) completed a card-guessing task, which robustly elicits VS reactivity. ELS, anhedonic symptoms, other depressive symptoms, coping behavior, and alcohol use behavior were assessed with self-report questionnaires. Linear regressions were run to examine whether VS reactivity moderated the relationship between ELS and anhedonic symptoms. Structural equation models examined whether this moderation was indirectly associated with other depression symptoms and problematic alcohol use through its association with anhedonia.
RESULTS: Analyses of data from 820 participants passing quality control procedures revealed that the VS × ELS interaction was associated with anhedonic symptoms (p = 0.011). Moreover, structural equation models indirectly linked this interaction to non-anhedonic depression symptoms and problematic alcohol use through anhedonic symptoms and substance-related coping.
CONCLUSIONS: These findings suggest that reduced VS reactivity to reward is associated with increased risk for anhedonia in individuals exposed to ELS. Such stress-related anhedonia is further associated with other depressive symptoms and problematic alcohol use through substance-related coping.

Entities:  

Keywords:  Alcohol; anhedonia; depression; early life stress; fMRI; reward; ventral striatum

Mesh:

Year:  2015        PMID: 25853627      PMCID: PMC4700837          DOI: 10.1017/S0033291715000525

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  78 in total

1.  Tracking the hemodynamic responses to reward and punishment in the striatum.

Authors:  M R Delgado; L E Nystrom; C Fissell; D C Noll; J A Fiez
Journal:  J Neurophysiol       Date:  2000-12       Impact factor: 2.714

2.  Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity.

Authors:  Ryan Bogdan; Douglas E Williamson; Ahmad R Hariri
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

Review 3.  Stress, depression, and anhedonia: caveats concerning animal models.

Authors:  Hymie Anisman; Kim Matheson
Journal:  Neurosci Biobehav Rev       Date:  2005-04-22       Impact factor: 8.989

4.  Anhedonia and motivational deficits in rats: impact of chronic social stress.

Authors:  Rafal Rygula; Nashat Abumaria; Gabriele Flügge; Eberhard Fuchs; Eckart Rüther; Ursula Havemann-Reinecke
Journal:  Behav Brain Res       Date:  2005-04-14       Impact factor: 3.332

5.  Discriminant validity of the MASQ in a clinical sample.

Authors:  Mark J Boschen; Tian P S Oei
Journal:  Psychiatry Res       Date:  2007-02-12       Impact factor: 3.222

6.  Resilient individuals use positive emotions to bounce back from negative emotional experiences.

Authors:  Michele M Tugade; Barbara L Fredrickson
Journal:  J Pers Soc Psychol       Date:  2004-02

7.  Blunted response to feedback information in depressive illness.

Authors:  J D Steele; P Kumar; K P Ebmeier
Journal:  Brain       Date:  2007-06-24       Impact factor: 13.501

Review 8.  Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution.

Authors:  Matthew C Keller
Journal:  Biol Psychiatry       Date:  2013-10-15       Impact factor: 13.382

9.  Binge drinking among US adults.

Authors:  Timothy S Naimi; Robert D Brewer; Ali Mokdad; Clark Denny; Mary K Serdula; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

10.  Acute stress influences neural circuits of reward processing.

Authors:  Anthony J Porcelli; Andrea H Lewis; Mauricio R Delgado
Journal:  Front Neurosci       Date:  2012-11-01       Impact factor: 4.677

View more
  50 in total

1.  Stress and Decision Making: Effects on Valuation, Learning, and Risk-taking.

Authors:  Anthony J Porcelli; Mauricio R Delgado
Journal:  Curr Opin Behav Sci       Date:  2017-04

2.  Reward-Related Brain Activity Prospectively Predicts Increases in Alcohol Use in Adolescents.

Authors:  Johnna R Swartz; David G Weissman; Emilio Ferrer; Sarah J Beard; Catherine Fassbender; Richard W Robins; Paul D Hastings; Amanda E Guyer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-06-04       Impact factor: 8.829

3.  Prefrontal Executive Control Rescues Risk for Anxiety Associated with High Threat and Low Reward Brain Function.

Authors:  Matthew A Scult; Annchen R Knodt; Spenser R Radtke; Bartholomew D Brigidi; Ahmad R Hariri
Journal:  Cereb Cortex       Date:  2019-01-01       Impact factor: 5.357

4.  Reward-related ventral striatum activity links polygenic risk for attention-deficit/hyperactivity disorder to problematic alcohol use in young adulthood.

Authors:  Caitlin E Carey; Annchen R Knodt; Emily Drabant Conley; Ahmad R Hariri; Ryan Bogdan
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-03

5.  Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.

Authors:  Sarah A Eisenstein; Ryan Bogdan; Ling Chen; Stephen M Moerlein; Kevin J Black; Joel S Perlmutter; Tamara Hershey; Deanna M Barch
Journal:  J Psychiatr Res       Date:  2016-11-17       Impact factor: 4.791

6.  Neurobehavioral markers of resilience to depression amongst adolescents exposed to child abuse.

Authors:  Meg J Dennison; Margaret A Sheridan; Daniel S Busso; Jessica L Jenness; Matthew Peverill; Maya L Rosen; Katie A McLaughlin
Journal:  J Abnorm Psychol       Date:  2016-11

7.  Reward-Related Ventral Striatum Activity Buffers against the Experience of Depressive Symptoms Associated with Sleep Disturbances.

Authors:  Reut Avinun; Adam Nevo; Annchen R Knodt; Maxwell L Elliott; Spenser R Radtke; Bartholomew D Brigidi; Ahmad R Hariri
Journal:  J Neurosci       Date:  2017-09-18       Impact factor: 6.167

8.  Transdiagnostic psychiatry: a systematic review.

Authors:  Paolo Fusar-Poli; Marco Solmi; Natascia Brondino; Cathy Davies; Chungil Chae; Pierluigi Politi; Stefan Borgwardt; Stephen M Lawrie; Josef Parnas; Philip McGuire
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

9.  COMT Val(158) Met genotype is associated with reward learning: a replication study and meta-analysis.

Authors:  N S Corral-Frías; D A Pizzagalli; J M Carré; L J Michalski; Y S Nikolova; R H Perlis; J Fagerness; M R Lee; E Drabant Conley; T M Lancaster; S Haddad; A Wolf; J W Smoller; A R Hariri; R Bogdan
Journal:  Genes Brain Behav       Date:  2016-06       Impact factor: 3.449

10.  Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.

Authors:  Caitlin E Carey; Arpana Agrawal; Bo Zhang; Emily D Conley; Louisa Degenhardt; Andrew C Heath; Daofeng Li; Michael T Lynskey; Nicholas G Martin; Grant W Montgomery; Ting Wang; Laura J Bierut; Ahmad R Hariri; Elliot C Nelson; Ryan Bogdan
Journal:  J Abnorm Psychol       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.